Design, synthesis and bioactivity evaluation of tribactam β lactamase inhibitors

[1]  J. Frère,et al.  Kinetic Study of Two Novel Enantiomeric Tricyclic β-Lactams Which Efficiently Inactivate Class C β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.

[2]  J. Frère,et al.  Mechanistic diversity of beta-lactamases. , 1999, Biochemical Society transactions.

[3]  J. Frère,et al.  When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β‐lactams , 1999, Molecular microbiology.

[4]  M. Page,et al.  Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. , 1998, Journal of medicinal chemistry.

[5]  D. Livermore,et al.  Interactions of β-Lactamases with Sanfetrinem (GV 104326) Compared to Those with Imipenem and with Oral β-Lactams , 1998, Antimicrobial Agents and Chemotherapy.

[6]  R. Micetich,et al.  SYN-1012: A New β-Lactamase Inhibitor of Penem Skeleton , 1997 .

[7]  I. Massova,et al.  MOLECULAR BASES FOR INTERACTIONS BETWEEN BETA -LACTAM ANTIBIOTICS AND BETA-LACTAMASES , 1997 .

[8]  Alessandro Padova,et al.  Synthesis of a novel fluoro-tribactam utilising an N-fluorosulfonimide in the key step , 1996 .

[9]  S. Hanessian,et al.  Tricyclic β-lactams: total synthesis and antibacterial activity of 5α- and 5β-methoxy-tribactams , 1995 .

[10]  K. Coleman.  Section Review: Anti-infectives: An update on β-lactamases and β-lactamase inhibitors , 1995 .

[11]  G. Gaviraghi,et al.  Synthesis and biological evaluation of 4-heterotribactams , 1995 .

[12]  J. Frère,et al.  Beta‐lactamases and bacterial resistance to antibiotics , 1995, Molecular microbiology.

[13]  S. M. Hammond,et al.  In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria , 1994, Antimicrobial Agents and Chemotherapy.

[14]  R. Volante,et al.  A stereoselective synthesis of a key 1β-methylcarbapenem intermediate via a diastereoselective decarboxylation , 1994 .

[15]  K. Bush,et al.  Kinetic interactions of tazobactam with beta-lactamases from all major structural classes , 1993, Antimicrobial Agents and Chemotherapy.

[16]  C. Sanders.  beta-Lactamases of gram-negative bacteria: new challenges for new drugs. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. W. Page,et al.  In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor , 1989, Antimicrobial Agents and Chemotherapy.

[18]  A. Yoshida,et al.  An Efficient Carbapenem Synthesis via an Intramolecular Wittig Reaction of New Trialkoxyphosphorane‐thiolesters. , 1984 .

[19]  A. Bedeschi,et al.  The carbonyl-carbonyl coupling route to penems : a stepwise analysis , 1984 .

[20]  S. McCombie,et al.  Homogeneous, palladium(0)-catalyzed exchange deprotection of allylic esters, carbonates and carbamates , 1982 .

[21]  J. Inanaga,et al.  Use of 1,8-diazabicyclo(5.4.0)undec-7-ene in preparation of trimethylsilyl enol ethers and trimethylsilylacetylenes. , 1981 .

[22]  R. Woodward,et al.  The penems, a new class of .beta.-lactam antibiotics. 3. Synthesis of optically active 2-methyl-(5R)-penem-3-carboxylic acid , 1979 .

[23]  F. Westheimer,et al.  Catalysis by molecular sieves in the preparation of ketimines and enamines , 1971 .